SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,947 | -55.0% | 522 | -57.7% | 0.01% | -59.3% |
| Q4 2022 | $160,031 | -4.7% | 1,235 | -18.9% | 0.03% | -22.9% |
| Q3 2022 | $168,000 | +14.3% | 1,522 | -22.1% | 0.04% | +25.0% |
| Q2 2022 | $147,000 | -34.4% | 1,955 | -31.7% | 0.03% | -31.7% |
| Q1 2022 | $224,000 | -13.2% | 2,863 | 0.0% | 0.04% | -18.0% |
| Q4 2021 | $258,000 | -5.8% | 2,863 | -3.3% | 0.05% | -13.8% |
| Q3 2021 | $274,000 | +16.1% | 2,961 | -2.3% | 0.06% | +16.0% |
| Q2 2021 | $236,000 | +95.0% | 3,032 | +86.1% | 0.05% | +85.2% |
| Q1 2021 | $121,000 | +31.5% | 1,629 | +202.8% | 0.03% | +17.4% |
| Q4 2020 | $92,000 | -34.8% | 538 | -46.3% | 0.02% | -46.5% |
| Q3 2020 | $141,000 | -11.9% | 1,001 | 0.0% | 0.04% | -20.4% |
| Q2 2020 | $160,000 | +63.3% | 1,001 | 0.0% | 0.05% | +35.0% |
| Q1 2020 | $98,000 | -26.3% | 1,001 | -3.4% | 0.04% | -41.2% |
| Q4 2019 | $133,000 | – | 1,036 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |